Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Total Current Liabilities (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Total Current Liabilities for 16 consecutive years, with $54.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities rose 139.09% to $54.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $54.4 million, a 139.09% increase, with the full-year FY2024 number at $55.0 million, up 107.06% from a year prior.
  • Total Current Liabilities was $54.4 million for Q3 2025 at Harvard Bioscience, down from $55.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $55.6 million in Q1 2025 to a low of $20.7 million in Q1 2021.
  • A 5-year average of $30.3 million and a median of $23.5 million in 2021 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: dropped 14.72% in 2023, then soared 144.03% in 2025.
  • Harvard Bioscience's Total Current Liabilities stood at $25.3 million in 2021, then decreased by 8.16% to $23.2 million in 2022, then increased by 14.16% to $26.5 million in 2023, then surged by 107.06% to $55.0 million in 2024, then dropped by 1.02% to $54.4 million in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Total Current Liabilities are $54.4 million (Q3 2025), $55.2 million (Q2 2025), and $55.6 million (Q1 2025).